Post-approval studies (Phase 4)Study completedNCT02959255
What this trial is testing
10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection
Who this might be right for
Helicobacter Pylori Infection
Elpen Pharmaceutical Co. Inc. 364